Comments

  1. […] The experimental serum consists of three "humanized" monoclonal antibodies as noted here: Local Biotech Increasing Production of 'ZMapp' Ebola Drug | Times of San Diego This combination seems very promising, as the monoclonal antibodies appear to block the virus […]

  2. […] is scaring the hell out of everyone now. It’s the disease du jour. Money well-spent on research will, hopefully, combat this pestilence. Kudos to Mapp Biopharmecutical for their work, and thanks to Kindra Luthi for her posting this […]

  3. […] le Times of San Diego , »Mapp Biopharmaceutical » a déclaré dans un communiqué que ZMapp est […]

  4. […] California biotechReuters IndiaSan Diego Pharmaceutical Company Behind Ebola MedicineNBC 7 San DiegoTimes of San Diego -Bayoubuzzall 25 news […]

  5. […] Times of San Diego reported a company spokesperson as saying: 'ZMapp was first identified as a drug candidate in January 2014 and has not yet been evaluated for safety in humans. As such, very little of the drug is currently available. […]

  6. […] An experimental drug given to two Americans to fight the ebola virus seems to be working, according to CNN. ZMapp was developed by San Diego-based Mapp Biopharmaceuticals and is currently working with governments and businesses to amp up production, according to the Times of San Diego. […]

  7. […] Forbes Times of San Diego Guardian LV […]

  8. […] Sources:ForbesTimes of San DiegoGuardian LVCBS8 […]

  9. […] Sources:ForbesTimes of San DiegoGuardian LVCBS8 […]

  10. […] per valutarne la sicurezza e la tossicità), ma in mancanza di alternative più valide si sta procedendo alla produzione su più ampia scala “per uso compassionevole”, una dicitura che ne permette l’uso in casi di emergenza anche […]

  11. […] ZMapp wurde von der amerikanischen Biotechnologiefirma Mapp Biopharmaceutical Inc. entwickelt, die ihren Sitz im kalifornischen San Diego hat. Mapp arbeitet eng mit dem US-Militär und dem Nationalen Gesundheitsinstitut (NIH) der Regierung zusammen. Nach basement jüngsten Meldungen wurden Fragen laut, ob das Antiserum nicht in größeren Mengen hergestellt werden könne. “Wir tun derzeit alles, um dazu beizutragen, basement Ausbruch von Ebola in Westafrika einzudämmen”, sagte der Präsident von Mapp Biopharmaceutical, Larry Zeitlin, der “Times of San Diego”. […]